Regulatory and Market Considerations of Recent Part D Rebate Regulations by Alvarez & Marsal
The Rise of Telehealth Amidst a Global Pandemic: Part III – The Future of Telehealth by Alvarez & Marsal
Part II: President Biden’s COVID-19 Plan, Campaign Promises Around Healthcare and What’s to Come for Prescription Drug Pricing In this 3-part series, you will...
Earlier this year, CMS finalized multiple rules that impact MAOs, with significant ramifications to procedures for RADV audits. Listen as A&M Healthcare Industry Group...